2014
Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities
Bowman S, Grau LE, Singer M, Scott G, Heimer R. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities. BMC Public Health 2014, 14: 820. PMID: 25107530, PMCID: PMC4138371, DOI: 10.1186/1471-2458-14-820.Peer-Reviewed Original ResearchConceptsInjection drug usersSyringe exchange programsThree-dose vaccine seriesVaccine seriesVaccination ratesDrug usersHealth interventionsStandard HBV vaccination scheduleBackgroundHepatitis B virusHBV vaccination scheduleVaccine series completionVaccine-preventable infectionsSelf-rated health scoresPublic health interventionsDeterminants of completionHepatitis vaccinationVaccine scheduleVaccination schedulePersonal health statusLast visitLongstanding recommendationsPreventable infectionsB virusHealth beliefsHealth scores
2011
Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions
Beletsky L, Grau LE, White E, Bowman S, Heimer R. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions. Drug And Alcohol Dependence 2011, 119: 145-149. PMID: 21705159, PMCID: PMC3192926, DOI: 10.1016/j.drugalcdep.2011.05.034.Peer-Reviewed Original ResearchConceptsSyringe exchange programsInjection drug usersNeedle stick injuriesCommunity-based prevention initiativesPublic health benefitsStick injuriesHIV transmissionPublic health rationaleDrug usersMost program managersMultivariate analysisSyringe possessionPrevention initiativesEvidence baseHealth benefitsCommunity healthOccupational healthHealth rationaleMultivariate modelingPrevalenceStructural interventionsSEP operationsPredictorsHealthPrevious year
2010
Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies
Green TC, Bluthenthal RN, Singer M, Beletsky L, Grau LE, Marshall P, Heimer R. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies. Drug And Alcohol Dependence 2010, 111: 74-81. PMID: 20537814, PMCID: PMC3087197, DOI: 10.1016/j.drugalcdep.2010.03.022.Peer-Reviewed Original ResearchConceptsSyringe exchange programsSEP usersSEP useThree-City cohort studyPolicy change analysisSyringe exchange usePredictors of transitionSecondary syringe exchangePolice contactCohort studyFemale sexHIV riskSyringe availabilityExchange useSyringe exchangeDrug usersDrug paraphernaliaHealth interventionsUS citiesLatino ethnicityIDUsPolicyContextual factorsMultinomial regressionTypology
2009
Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users
Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.Peer-Reviewed Original ResearchRisk reduction materialsSyringe exchange programsInjection drug usersHygiene suppliesDrug usersHealth promotion behaviorsAppropriate useHealth promotion materialsSEP clientsPrevention interventionsHepatitis riskBlood flowInjection practicesPromotion behaviorsInjection siteBrief interventionIntervention effectivenessIntervention packetInterventionPassive introductionPromotion materialsExchange programsOne-quarterSubstantial numberVerbal reminders
2008
Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Hu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users. American Journal Of Preventive Medicine 2008, 35: 25-32. PMID: 18541174, PMCID: PMC2483306, DOI: 10.1016/j.amepre.2008.03.028.Peer-Reviewed Original ResearchConceptsInjection drug usersSyringe exchange programsHBV vaccinationDrug usersHepatitis B vaccination coverageActive injection drug usersAcute HBV infectionHepatitis B infectionHepatitis B vaccineQuality-adjusted life yearsAbsence of vaccinationLocal health departmentsDifferent vaccination strategiesVaccination program costsB infectionHBV infectionB vaccineFirst doseVaccination scheduleVaccination coverageVaccination strategiesCost-saving strategyVaccination campaignHigh riskMedical costsHepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign
Heimer R, Grau L, Singer M, Scott G, Marshall P, Hu Y, Seal K. Hepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign. Journal Of Drug Issues 2008, 38: 335-350. DOI: 10.1177/002204260803800114.Peer-Reviewed Original ResearchInjection drug usersVaccination ratesDrug usersHepatitis B virus (HBV) prevalencePast hepatitis B infectionHepatitis B virus infectionHispanic injection drug usersHepatitis B infectionHepatitis B vaccinationB virus infectionDoses of vaccineNon-Hispanic blacksCurrent drug useSyringe exchange programsNon-Hispanic whitesB vaccinationB infectionHepatitis infectionHepatitis BEffective vaccineVirus infectionStudy populationVaccination campaignHigh riskDrug use
2005
Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs
Grau LE, Bluthenthal RN, Marshall P, Singer M, Heimer R. Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs. AIDS And Behavior 2005, 9: 495-504. PMID: 16237501, DOI: 10.1007/s10461-005-9020-3.Peer-Reviewed Original ResearchConceptsSyringe exchange programsHIV risk characteristicsC virus infectionHIV prevention messagesOnly psychosocial factorHepatitis BObservational studyVirus infectionDrug injectorsPsychosocial factorsInjection sitePrevention messagesRisk profilePsychosocial characteristicsReported historyFuture interventionsStudy sampleIDUsExchange programsProgram effectivenessHIVRisk characteristicsInfection